Novo Holdings's Biotechnology Portfolio

Tempus develops AI-enabled precision medicine technology that supports clinical decision-making and biomedical research.

cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions.

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.

Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.

Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.

The Protein Brewery specializes in developing and making animal-free-based protein in a sustainable way.

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.

Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.

HepaRegeniX is developing drugs for treating acute and chronic liver diseases.

Tribune Therapeutics specializes in building promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.

Callio Therapeutics develops next-generation, multi-payload antibody-drug conjugates (ADCs).

Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.

Commit Biologics is a biotechnology research company developing a novel immunotherapy platform for the treatment of cancer.

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.

Draupnir Bio is developing a new type of cholesterol-lowering medicine which prevents blood clots in the heart.

Myricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer.

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

Asgard Therapeutics is a Biotechnology Company.

Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.

Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

Chromologics develops innovative natural food colorants.

Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.

Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.

Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.

Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.

Bactolife is a biotechnology company that develops biological solutions to support gut health.

Booster Therapeutics is a biotech company that offers regulation of cellular homeostasis, as well as develops medicines for aging diseases.

Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.

Cleveland Diagnostics is a diagnostics company developing efficacious, affordable diagnostics tests to improve cancer diagnostics.

LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.

KalVista Pharmaceuticals is an ophthalmology company focused on developing drugs for the treatment of diabetic macular edema (DME).

Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.

MedGenome develops a genomics-based diagnostics and research solution for healthcare providers to understand the genetic basis of diseases.

Glycomine is an early-stage biotech working on replacement therapies for rare diseases.

Hillstar Bio is developing precision immunotherapies to treat autoimmune diseases.

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars.

Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.

Antag Therapeutics provides therapeutic peptides for the treatment of dietary-related metabolic diseases.

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.

Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system.

Revagenix is a biopharmaceutical company discovering and developing therapies to address medical needs.

Exscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.

Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.